Assyro AI
FDA Orange Book · active-ingredient family

Lindane

Lindane: 2 brands, 10 generics; first approved Apr 08, 1983; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available — 10 ANDA applications approved.

Brands (NDA)
2
Generics (ANDA)
10
Listed patents
0
Presentations
14
Originator applications

Brand (NDA) products

NDA 0063092 strengths
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%CREAMTOPICALDiscontinued
1%LOTIONTOPICALDiscontinued
NDA 010718
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%SHAMPOOTOPICALDiscontinued
Abbreviated applications

Generic (ANDA) products (10)

ANDA 0881911984
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%SHAMPOOTOPICALDiscontinued
ANDA 0881901984
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%LOTIONTOPICALDiscontinued
ANDA 0879401983
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%SHAMPOOTOPICALDiscontinued
ANDA 0842182 strengths
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%CREAMTOPICALDiscontinued
1%LOTIONTOPICALDiscontinued
ANDA 084989
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%LOTIONTOPICALDiscontinued
ANDA 087313
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%LOTIONTOPICALDiscontinued
ANDA 086769
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%LOTIONTOPICALDiscontinued
ANDA 084988
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%SHAMPOOTOPICALDiscontinued
ANDA 084219
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%SHAMPOOTOPICALDiscontinued
ANDA 087266
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
1%SHAMPOOTOPICALDiscontinued
Orange Book patent file

Listed patents

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

FDA approval span

Approval history

First approval
Apr 08, 1983
43 yr 11 mo ago
Most recent approval
Sep 18, 1984
42 yr 5 mo ago

Approvals span 1983–1984 across 12 FDA applications.

Brand (NDA) 217%
Generic (ANDA) 1083%

Lindane — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.